Rocket Pharmaceuticals Return on Net Operating Assets Insights

Rocket Pharmaceuticals, Inc. (RCKT)

3.51 +0.09 (+2.63%) USD | NASDAQ | Dec 31, 16:00

3.515 0.00 (0.00%) After-Hours: 20:00

View Return on Net Operating Assets for RCKT.
Upgrade now.

Sep '18

Jan '19

May '19

285.00

270.00

255.00

240.00

View Return on Net Operating Assets Chart

Start Trial

View Historical Data

Start Trial

View Return on Net Operating Assets Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

View Return on Net Operating Assets Benchmarks

Start Trial

Alnylam Pharmaceuticals, Inc.	Upgrade
Merck & Co., Inc.	Upgrade
Avalo Therapeutics, Inc.	Upgrade
Artiva Biotherapeutics, Inc.	Upgrade
NovaBay Pharmaceuticals, Inc.	Upgrade